Stay updated on Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial

Sign up to get notified when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:30:58.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, tolerability, and efficacy evaluation of ZX008 (fenfluramine hydrochloride) as adjunctive therapy in children and young adults with Dravet syndrome.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:55.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying age, gender, and medical history requirements. Previously, no information was provided under Participation Criteria for Collaborators and Investigators.
    Difference
    24%
    Check dated 2024-05-22T21:01:09.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:22:34.000Z thumbnail image

Stay in the know with updates to Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.